D-0003-2026 Class II Terminated
FDA drug recall D-0003-2026 was initiated by RC Outsourcing, LLC on Sep 22, 2025 and is designated Class II. Reason for recall: Lack of assurance of sterility. The recall status is terminated (terminated Jan 5, 2026). Affected quantity: 2,669 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 15, 2025
- Initiation Date
- Sep 22, 2025
- Termination Date
- Jan 5, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,669 syringes
Product description
Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.
Reason for recall
Lack of assurance of sterility.
Distribution pattern
Nationwide in the US
Code information
Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0003-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026